du Bois Score for Idiopathic Pulmonary Fibrosis (IPF) Mortality

The du Bois Score estimates 1‑year mortality risk in IPF using age, recent respiratory hospitalization, baseline FVC%, and 24‑week FVC change.

Age
< 60 years060-69 years+4≥ 70 years+8
Respiratory hospitalization in past 6 months
No0Yes+14
Predicted baseline FVC
≥ 80%066-79%+851-65%+13≤ 50%+18
24-week change in predicted FVC
≥ -4.9%0-5% to -9%+10≤ -10%+21

Indications for Use

Used to estimate 1‑year mortality risk in IPF using age, recent respiratory hospitalization, baseline FVC%, and 24‑week FVC change, the four validated predictors from the du Bois clinical model (C‑statistic 0.75 in 1,099 trial patients) 1 [Level I evidence].
Clinical utility: risk‑stratification, timing of antifibrotic therapy, transplant referral, and prognostic counseling in established IPF.

Insights & Cautions

Predicts 1‑year mortality using age, baseline FVC% and 24‑week FVC change, plus recent respiratory hospitalization, but accuracy is modest and derived from clinical trial cohorts 1 [Level II evidence]. Use cautiously because external validation is limited, progression is heterogeneous, and newer multidimensional models (e.g., GAP, longitudinal GAP) often outperform it for individualized risk estimation 2 [Level II evidence].